JY306 Universal NK Cell Injection

· The First Affiliated Hospital with Nanjing Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JY306 Universal NK Cell Injection, covering 2025-02-20 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors [EARLY_Phase 1]

See pricing